A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3 randomized controlled trial (the Mirai study).

2025

https://researcherprofiles.org/profile/679826119

40378969

Rothman B, Slomkowski M, Speier A, Rush AJ, Trivedi MH, Lakhan SE, Lawson E, Fahmy M, Carpenter D, Chen D, Docherty JP, Forbes A